The determination of phenolic compounds in artichoke flower head extracts by HPLC GC/MS technique by Fedosov, Andrei et al.
Scripta Scientifica Pharmaceutica, vol. 3, No. 2, 2016, online first  
Medical University of Varna   23
ORIGINAL ARTICLES
THE DETERMINATION OF PHENOLIC COMPOUNDS IN 
ARTICHOKE FLOWER HEAD EXTRACTS BY HPLC GC/MS 
TECHNIQUE
Andrei Fedosov1, Oleksandra Kyslychenko1, Andrei Gudzenko2, Olga Semenchenko2, 
Victoriia Kyslychenko1
1National University of Pharmacy, Kharkiv, Ukraine 
2Government Agency “Institute of Pharmacology and Toxicology, National Academy of 
Medical Science of Ukraine”, Kyiv, Ukraine
Address for correspondence:  
Victoriia Kyslychenko




Received: June 7, 2016
Accepted: November 4, 2016
INTRODUCTION
Being a popular ingredient in Mediterranean 
cuisine, artichoke was used as a treatment agent 
since ancient times (1,10). Artichoke had an effect 
on gastro-intestinal tract dysfunction and disorders 
(2,5,10,14,15). This delicious plant showed choleret-
ic, diuretic, and antirheumatic activities as well as a 
coagulant effect in liver and kidneys (10-12,15). De-
spite wide application in official and folk medicine 
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(15), artichoke flower heads are still of great interest 
among the scientists. During the first part of twenti-
eth century some new effects of artichoke were dis-
covered. This plant turned out to improve liver func-
tioning, protect from liver fat degeneration caused 
by arsenic compounds as well as decrease cholester-
ol level (3,4,6,13,15). 1990s was an important peri-
od in artichoke studies. This decade went into his-
tory as the time of cynarin structure discovery and 
exploration of cell-protection action on isolated sec-
ondary hepatocytes and cholesterol biosynthesis de-
crease (9,10). 
The lack of side-effects in combination with fe-
tus protection activity makes artichoke remedies and 
dietary products an important part of a therapy dur-
ing pregnancy (10,15). However, an ongoing inter-
est in artichoke demands precise sample preparation 
procedures for extracts obtaining further standard-
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ization of the extracts for future use in a prospective 
artichoke drug design.
MATERIALS AND METHODS
Dry artichoke flower heads (inflorescences) 
was the plant raw material which was selected as the 
object of research.
The studied solutions were prepared in the fol-
lowing way (7). 
Methanol Solution Preparation 
5 g of plant raw material - dry artichoke flower 
heads (inflorescences) was put into a round-bottom 
flask with further addition of 125.0 ml of methanol 
and boiling it in a water bath with a reflux condens-
er for 1 hour. Later on it was cooled, filtered through 
“blue stripe” paper filter (solution 1). The solvent was 
added to 5.0 ml of the obtained solution in amount 
enough to get 10.0 ml in total volume.
Extract Preparation after Hydrolysis
5.0 ml of solution 1 was put into a round-bot-
tom flask with the further addition of 5.0 ml of hy-
drochloric acid. The obtained solution was boiled 
in a water bath with a reflux condenser for 30 min. 
Afterwards it was cooled and put into a 25 ml volu-
metric flask. The volume was increased with meth-
anol up to the flask mark, then mixed and filtered 
through “blue stripe” paper filter. The solvent was 
added to 5.0 ml of the obtained solution in amount 
enough to get 10.0 ml in total volume. The next step 
was conduction of a chromatographic analysis. 
The chromatographic study of the tested ex-
tracts and standard samples solutions was carried 
out with the help of Agilent 1200 LC/MSD chro-
matograph which consisted of a pump unit G1312A, 
degasser G1322A, column thermostat G1316A, autos-
ampler G1367B, diode-matrix detector G1315D and 
quadrupole mass spectrometer Agilent 6130. Chro-
matography was carried out under such conditions: 
a column made of a stainless steel С18 SunFire (150 
x 4.6 mm, 3.5 µm); the column temperature – 380С; 
diode-matrix detector detection wavelength was 254 
nm, 330 nm, 350 nm, 360 nm, 370 nm. Mass detec-
tor detection conditions were the following: ioniza-
tion – electric spray, scanning in the range of 150-
800 m/z (positive and negative ionization); fragmen-
tation – 70; gain -1.0; the flow rate of a mobile phase 
was 1 ml/min; the injected sample volume was 50 µl. 
The mobile phase was the following:
Hyperoside, rutin, apigenin-7-glucoside, luteo-
lin-7-glucoside and luteolin solutions as well as caf-
feic acid, rosmarinic acid and chlorogenic acid solu-
tions in methanol were used as standard solutions. 
While working, the following reagents were 
used: acetonitrile and methanol for gradient chroma-
tography (“FLUKA” (Germany)); formic acid (“FLU-
KA” (Germany)); rectified ethanol (according to the 
Pharmacopoeia requirements), and water. 
The obtained data were analyzed using Stu-
dent’s t-test.
RESULTS AND DISCUSSION 
Table 1 shows the data regarding the retention 
time of standard substances under the conditions of 
the studied chromatography technique.
The chromatograms of the standard com-
pounds are shown in Fig. 1-8.
Time, minutes Mobile phase А, %(turnover/turnover)
Mobile phase В, %
(turnover/turnover) Mode
0→1 92 8 isocratic
1→15 92→70 8→30 gradient
15→25 70→0 30→100 gradient
25→33 0 100 isocratic
33→33.5 0→92 100→8 gradient
Mobile phase А – 0.1% formic acid solution;
Mobile phase В – 0.1% formic acid solution in the mixture (acetonitrile:methanol 1:1).
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Compound Name Formula Molecular mass [М-Н]– (m/z)
Hyperoside C27H30O16 610.15 465
Rutin C15H10O6 286.05 611
Luteolin C21H20O11 448.10 287
Luteolin-7-glucoside C21H20O10 432.11 449
Apigenin-7-glucoside C9H8O4 180.04 433
Chlorogenic acid C16H18O9 354.10 355
Caffeic acid C18H16O8 360.08 179
Rosmarinic acid C16H18O9 354.10 359
Table 1. Physicochemical characteristics of phenolic compounds
Fig. 1. The chromatogram of luteolin standard solution 
[+287 u]
Fig. 2. The chromatogram of chlorogenic acid standard 
solution [+355 u]
Fig. 3. The chromatogram of apigenin–7-glucoside stan-
dard solution [+433 u]
Fig. 4. The chromatogram of luteolin-7-glucoside stan-
dard solution [+449 u]
Fig. 5. The chromatogram of hyperoside standard solu-
tion [+465 u]
Fig. 6. The chromatogram of rutin standard solution 
[+611 u]
Fig. 7. The chromatogram of the caffeic acid standard so-
lution [–179 u]
Fig. 8. The chromatogram of the rosmarinic acid standard 
solution [–359 u]
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Figures 9-10 show chromatograms of the stud-
ied solutions. The studied compounds in the solu-
tions tested were identified by retention time as well 
as by m/z index. 
Fig. 9 represents the chromatograms of the test-
ed solutions obtained under conditions of positive 
ionization. Fig. 10 represents the chromatograms of 
the tested solutions obtained under conditions of 
negative ionization. 
The data regarding the obtained components 
and their concentrations in the solutions studied are 
presented in Table 2. 
According to the data presented in Table 2 all 
the studied standard compounds were identified in 
the tested methanol extract (7,8,13). The dominant 
components were apigenin-7-glucoside and chlo-
rogenic acid with concentration of 0.75701% and 
0.51378%, respectively. Luteolin, caffeic acid, lute-
olin-7-glucoside and hyperoside were identified in 
lower concentration – 0.13217%, 0.05216%, 0.03117% 
and 0.00087%, respectively. Rutin and rosmarinic 
acid were represented in the tested solution only in 
trace amounts. 
According to the data represented in Table 2, 
only 4 compounds – apigenin-7-glucoside, luteolin, 
chlorogenic acid and luteolin-7-glucoside were identi-
fied in the extract after hydrolysis. The concentration 
of the compounds mentioned above was 0.16639%, 
0.02468%, 0.00563% and 0.00242%, respectively.
CONCLUSIONS 
New remedies and diet supplements are ap-
pearing on the pharmaceutical market in Ukraine 
and abroad. The conducted research enables further 
standardization of artichoke-containing drugs and 
products based on the data provided below. 
1. The application of HPLC GC/MS method of 
analysis helped to work out a technique of de-
tection of 8 biologically active compounds in 
dry artichoke flower heads extracts. 
2. Methanol dry artichoke flower heads extract 
and methanol dry artichoke flower heads ex-
tract after hydrolysis were analyzed with the 
Fig. 9. Chromatograms of the studied extracts, positive 
ionization. The red line represents the methanol extract; 
the blue line represents the studied extract after hydrolysis
Fig. 10. Chromatograms of the studied extracts, negative 
ionization. The red line represents the methanol extract; 
the blue line represents the studied extract after hydrolysis
Studied component
Artichoke extract after hydrolysis Methanol artichoke extract
Content in %, based on a dry substance
Luteolin 0.02468 0.13217
Chlorogenic acid 0.00563 0.51378
Apigenin–7-glucoside 0.16639 0.75701
Luteolin-7-glucoside 0.00242 0.03117
Hyperoside trace amount 0.00087
Rutin trace amount trace amount
Caffeic acid trace amount 0.05216
Rosmarinic acid trace amount trace amount
Table 2. Results of a quantitative determination of the studied components in methanol and artichoke extracts after 
hydrolysis
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help of the developed technique. As the re-
sult of the conducted research luteolin-7-glu-
coside, luteolin, apigenin-7-glucoside, hyper-
oside, rutin, caffeic acid, chlorogenic acid and 
rosmarinic acid were identified in the studied 
methanol extract. Wherein, apigenin-7-glu-
coside and chlorogenic acid were present at 
the highest amount– 0.75701% and 0.51378% 
based on a dry substance, respectively. 
3. Only four compounds – apigenin-7-glucoside, 
luteolin, chlorogenic acid and luteolin-7-glu-
coside were identified in the studied extract 
after hydrolysis. The concentration of the 
compounds mentioned above was 0.16639%, 
0.02468%, 0.00563%, and 0.00242% based on 
dry substance, respectively.
4. HPLC technique is the validated quality con-
trol technique of the obtained extract.
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